Income StatementBalance SheetCash FlowSegments
Agilent Technologies logo

Agilent Technologies Business Segments

Business, geographic, and product segment breakdowns

Agilent Technologies generates $7.1B in annual revenue across 3 key segments: Agilent CrossLab ($1.2B), Applied Markets ($585.0M), and Life Sciences and Diagnostics Markets ($1.1B). The company-wide operating margin is 20.61%. Based on the Q4 2025 filing.

Agilent CrossLab (TTM)$1.2BApplied Markets (TTM)$585.0MLife Sciences and Diagnostics Markets (TTM)$1.1B
Latest FilingQ4 2025
Report Date2026-03-03
Market Cap$32.0B
P/E Ratio24.81
ROE19.95%

Products & Services

Net revenue

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Non-Instrumentation and Other$1.1B$1.1B$1.1B$1.1B$1.2B$1.1B
Instrumentation$620.0M$625.0M$550.0M$599.0M$653.0M$658.0M
Services and Other$484.0M$481.0M$482.0M$508.0M$533.0M$525.0M

Cost of revenue

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Services and Other$247.0M$247.0M$264.0M$273.0M$284.0M$281.0M

Geographic

Net revenue

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Americas$680.0M$669.0M$678.0M$683.0M$776.0M$678.0M
Asia Pacific$567.0M$549.0M$548.0M$563.0M$559.0M$602.0M
Europe$454.0M$463.0M$442.0M$492.0M$526.0M$518.0M

Cash & Equivalents

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Non-US$1.3B———$1.7B—

Long-Lived Assets

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Rest Of World$529.0M———$532.0M—

Business Segments

Goodwill Foreign Currency Translation Gain Loss

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Agilent Cross Lab$500.0K$0.0$0.0$0.0$0.0—

Cost of revenue

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Agilent CrossLab$296.3M$306.0M———$340.0M
Life Sciences and Diagnostics Markets$280.3M$305.0M———$336.0M
Applied Markets$145.0M$150.0M———$157.0M

Depreciation

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Life Sciences and Diagnostics Markets$18.0M$23.0M———$26.0M
Agilent CrossLab$7.3M$14.0M———$14.0M
Applied Markets$5.8M$6.0M———$6.0M

Foreign currency translation impact

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Applied Markets$1.0M-$5.0M$4.0M$1.0M$0.0$7.0M
Agilent CrossLab—-$4.0M$3.0M$1.0M—$3.0M
Life Sciences and Diagnostics Markets-$3.8M-$22.0M$26.0M-$1.0M—$1.0M

Goodwill

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Life Sciences and Diagnostics Markets$3.0B$3.0B$3.0B$3.0B$3.0B$3.0B
Agilent CrossLab$1.2B$1.2B$1.2B$1.2B$1.2B$1.2B
Applied Markets$309.0M$304.0M$308.0M$309.0M$309.0M$316.0M

Income from operations

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Agilent CrossLab$139.0M$221.0M$231.0M$248.0M$246.0M$240.0M
Life Sciences and Diagnostics Markets$141.0M$117.0M$129.0M$118.0M$172.0M$109.0M
Applied Markets$86.0M$84.0M$59.0M$71.0M$87.0M$93.0M

Net revenue

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Agilent CrossLab$426.0M$696.0M$713.0M$744.0M$755.0M$758.0M
Life Sciences and Diagnostics Markets$657.0M$647.0M$654.0M$670.0M$755.0M$679.0M
Applied Markets$338.0M$338.0M$301.0M$324.0M$351.0M$361.0M

Research and Development Expense

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Life Sciences and Diagnostics Markets$62.5M$63.0M———$65.0M
Agilent CrossLab$26.3M$26.0M———$28.0M
Applied Markets$23.5M$23.0M———$24.0M

Selling, General and Administrative Expense

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Life Sciences and Diagnostics Markets$152.8M$162.0M———$169.0M
Agilent CrossLab$133.0M$143.0M———$150.0M
Applied Markets$77.8M$81.0M———$87.0M

Share-based compensation expense

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Agilent CrossLab$7.3M$16.0M———$16.0M
Life Sciences and Diagnostics Markets$11.5M$15.0M———$14.0M
Applied Markets$6.0M$8.0M———$7.0M